1424 related articles for article (PubMed ID: 28087505)
1. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
van der Heijde D; Ramiro S; Landewé R; Baraliakos X; Van den Bosch F; Sepriano A; Regel A; Ciurea A; Dagfinrud H; Dougados M; van Gaalen F; Géher P; van der Horst-Bruinsma I; Inman RD; Jongkees M; Kiltz U; Kvien TK; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compàn V; Ozgocmen S; Pimentel-Santos FM; Reveille J; Rudwaleit M; Sieper J; Sampaio-Barros P; Wiek D; Braun J
Ann Rheum Dis; 2017 Jun; 76(6):978-991. PubMed ID: 28087505
[TBL] [Abstract][Full Text] [Related]
2. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ramiro S; Nikiphorou E; Sepriano A; Ortolan A; Webers C; Baraliakos X; Landewé RBM; Van den Bosch FE; Boteva B; Bremander A; Carron P; Ciurea A; van Gaalen FA; Géher P; Gensler L; Hermann J; de Hooge M; Husakova M; Kiltz U; López-Medina C; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compán V; Nissen MJ; Pimentel-Santos FM; Poddubnyy D; Proft F; Rudwaleit M; Telkman M; Zhao SS; Ziade N; van der Heijde D
Ann Rheum Dis; 2023 Jan; 82(1):19-34. PubMed ID: 36270658
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
Webers C; Ortolan A; Sepriano A; Falzon L; Baraliakos X; Landewé RBM; Ramiro S; van der Heijde D; Nikiphorou E
Ann Rheum Dis; 2023 Jan; 82(1):130-141. PubMed ID: 36270657
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
Ortolan A; Webers C; Sepriano A; Falzon L; Baraliakos X; Landewé RB; Ramiro S; van der Heijde D; Nikiphorou E
Ann Rheum Dis; 2023 Jan; 82(1):142-152. PubMed ID: 36261247
[TBL] [Abstract][Full Text] [Related]
5. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Gossec L; Baraliakos X; Kerschbaumer A; de Wit M; McInnes I; Dougados M; Primdahl J; McGonagle DG; Aletaha D; Balanescu A; Balint PV; Bertheussen H; Boehncke WH; Burmester GR; Canete JD; Damjanov NS; Kragstrup TW; Kvien TK; Landewé RBM; Lories RJU; Marzo-Ortega H; Poddubnyy D; Rodrigues Manica SA; Schett G; Veale DJ; Van den Bosch FE; van der Heijde D; Smolen JS
Ann Rheum Dis; 2020 Jun; 79(6):700-712. PubMed ID: 32434812
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
7. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Smolen JS; Landewé R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg JE; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Poór G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D
Ann Rheum Dis; 2017 Jun; 76(6):960-977. PubMed ID: 28264816
[TBL] [Abstract][Full Text] [Related]
8. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
Braun J; Kiltz U; Baraliakos X
Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
[TBL] [Abstract][Full Text] [Related]
9. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Smolen JS; Landewé RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg JE; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Müller-Ladner U; Mysler EF; da Silva JAP; Poór G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
Ann Rheum Dis; 2020 Jun; 79(6):685-699. PubMed ID: 31969328
[TBL] [Abstract][Full Text] [Related]
10. Advances in pharmacotherapies for axial spondyloarthritis.
Toussirot E
Expert Opin Pharmacother; 2023; 24(13):1439-1448. PubMed ID: 37318776
[TBL] [Abstract][Full Text] [Related]
11. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.
Gossec L; Smolen JS; Ramiro S; de Wit M; Cutolo M; Dougados M; Emery P; Landewé R; Oliver S; Aletaha D; Betteridge N; Braun J; Burmester G; Cañete JD; Damjanov N; FitzGerald O; Haglund E; Helliwell P; Kvien TK; Lories R; Luger T; Maccarone M; Marzo-Ortega H; McGonagle D; McInnes IB; Olivieri I; Pavelka K; Schett G; Sieper J; van den Bosch F; Veale DJ; Wollenhaupt J; Zink A; van der Heijde D
Ann Rheum Dis; 2016 Mar; 75(3):499-510. PubMed ID: 26644232
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
Kerschbaumer A; Sepriano A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JWJ; Burmester GR; de Wit M; Falzon L; Landewé R
Ann Rheum Dis; 2020 Jun; 79(6):744-759. PubMed ID: 32033937
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
Sepriano A; Regel A; van der Heijde D; Braun J; Baraliakos X; Landewé R; Van den Bosch F; Falzon L; Ramiro S
RMD Open; 2017; 3(1):e000396. PubMed ID: 28176964
[TBL] [Abstract][Full Text] [Related]
14. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM; Deodhar A; Akl EA; Lui A; Ermann J; Gensler LS; Smith JA; Borenstein D; Hiratzka J; Weiss PF; Inman RD; Majithia V; Haroon N; Maksymowych WP; Joyce J; Clark BM; Colbert RA; Figgie MP; Hallegua DS; Prete PE; Rosenbaum JT; Stebulis JA; van den Bosch F; Yu DT; Miller AS; Reveille JD; Caplan L
Arthritis Rheumatol; 2016 Feb; 68(2):282-98. PubMed ID: 26401991
[TBL] [Abstract][Full Text] [Related]
15. 2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis.
Wendling D; Lukas C; Prati C; Claudepierre P; Gossec L; Goupille P; Hudry C; Miceli-Richard C; Molto A; Pham T; Saraux A; Dougados M
Joint Bone Spine; 2018 May; 85(3):275-284. PubMed ID: 29407043
[TBL] [Abstract][Full Text] [Related]
16. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.
Smolen JS; Landewé R; Breedveld FC; Buch M; Burmester G; Dougados M; Emery P; Gaujoux-Viala C; Gossec L; Nam J; Ramiro S; Winthrop K; de Wit M; Aletaha D; Betteridge N; Bijlsma JW; Boers M; Buttgereit F; Combe B; Cutolo M; Damjanov N; Hazes JM; Kouloumas M; Kvien TK; Mariette X; Pavelka K; van Riel PL; Rubbert-Roth A; Scholte-Voshaar M; Scott DL; Sokka-Isler T; Wong JB; van der Heijde D
Ann Rheum Dis; 2014 Mar; 73(3):492-509. PubMed ID: 24161836
[TBL] [Abstract][Full Text] [Related]
17. To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question.
Lukasik Z; Carron P; Webers C
Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101869. PubMed ID: 37658017
[TBL] [Abstract][Full Text] [Related]
18. New evidence on the management of spondyloarthritis.
Sieper J; Poddubnyy D
Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
[TBL] [Abstract][Full Text] [Related]
19. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
20. 2018 APLAR axial spondyloarthritis treatment recommendations.
Tam LS; Wei JC; Aggarwal A; Baek HJ; Cheung PP; Chiowchanwisawakit P; Dans L; Gu J; Hagino N; Kishimoto M; Reyes HM; Soroosh S; Stebbings S; Whittle S; Yeap SS; Lau CS
Int J Rheum Dis; 2019 Mar; 22(3):340-356. PubMed ID: 30816645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
